Randomized Phase 3 Trial Evaluating the Efficacy of Locoregional Treatment With Transarterial Embolization (TAE) for Liver Metastases, in Combination With Pharmacotherapy, in Patients With Neuroendocrine Tumor and Inoperable Liver Metastasis. (LOTUS)

NCT01755182 Phase 3 TERMINATED

The purpose of this study is to verify if adding a locoregional treatment of liver metastasis (with trans-arterial embolization-TAE) to medical treatments of proven efficacy can prolong the progression free survival of patients affected by neuroendocrine tumors (NET) with inoperable liver metastases

Details

Lead sponsor	National Cancer Institute, Naples
Phase	Phase 3
Status	TERMINATED
Enrolment	1
Start date	2013-07
Completion	2016-03

Conditions

• Neuroendocrine Tumors

Interventions

• approved pharmacologic therapy
• TAE

Primary outcomes

• progression free survival — two years

Countries

Italy